Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests

被引:12
作者
Bayley, PJ
Bentley, GD
Jackson, A
Williamson, D
Dawson, GR
机构
[1] Merck Sharp and Dohme Res. Labs., Neuroscience Research Centre, Harlow, Essex CM20 2QR, Terlings Park, Eastwick Road
[2] Lab. of Experimental Psychology, School of Biological Sciences, University of Sussex, Falmer, Brighton
关键词
diazepam; FG; 8205; flumazenil; quazepam; sedation; zolpidem;
D O I
10.1177/026988119601000305
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of four BZ receptor ligands in an operant test were compared with a rotarod test. In the operant test, rats were trained to pull a chain on a schedule that regulates the probability of delivery of food pellets to maintain a steady chain-pulling rate across alh test session. For the rotarod test, mice were trained to remain on a rotarod for 2 min. Diazepam (0.1-3.0 mg/kg, i.p) FG 8205 (0.1-3.0 mg/kg, i.p) quazepam (3.0-60.0 mg/kg, i.p.) and zolpidem (0.3-10.0 mg/kg, i.p.) each produced dose-related impairments of performance in both the chain-pulling test and the mouse rotarod test. Furthermore, the impairment in performance induced by FG 8205 (10.0 mg/kg, p.o.) was dose-dependently reversed by the BZ receptor antagonist, flumazenil (1.0-10.0 mg/kg, i.p.), indicating that the chain-pulling deficit was mediated via BZ receptor activation. Diazepam, FG 8205 and quazepam all had comparable potencies in both the rotarod assay and the chain-pulling test. However, zolpidem suppressed the chain-pulling rates at a dose 30-fold lower than that required to induce a significant deficit in the rotarod performance. As zolpidem is a preferentially sedative compound, this pattern of results is consistent with the hypothesis that the chain-pulling test is sensitive to sedation induced by BZ receptor agonists.
引用
收藏
页码:206 / 213
页数:8
相关论文
共 34 条
[1]   PHARMACOLOGICAL PROFILE OF THE IMIDAZOPYRIDINE ZOLPIDEM AT BENZODIAZEPINE RECEPTORS AND ELECTROCORTICOGRAM IN RATS [J].
ARBILLA, S ;
DEPOORTERE, H ;
GEORGE, P ;
LANGER, SZ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 330 (03) :248-251
[2]  
BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033
[3]  
BOURIN M, 1992, J PSYCHIATR NEUROSCI, V17, P72
[4]   LIGANDS FOR BENZODIAZEPINE RECEPTORS WITH POSITIVE AND NEGATIVE EFFICACY [J].
BRAESTRUP, C ;
HONORE, T ;
NIELSEN, M ;
PETERSEN, EN ;
JENSEN, LH .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (06) :859-862
[5]   GABA-A RECEPTOR SUBTYPES - FROM PHARMACOLOGY TO MOLECULAR-BIOLOGY [J].
BURT, DR ;
KAMATCHI, GL .
FASEB JOURNAL, 1991, 5 (14) :2916-2923
[6]  
CORRADI CL, 1985, SOC NEUR ABSTR, V1, P425
[7]  
DAWSON GR, 1990, Q J EXP PSYCHOL-B, V42, P225
[8]  
DAWSON GR, 1995, PSYCHOPHARMACOLOGY, V113, P570
[9]   MULTIPLE BENZODIAZEPINE RECEPTORS - NO REASON FOR ANXIETY [J].
DOBLE, A ;
MARTIN, IL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (02) :76-81
[10]   A NOTE ON A SIMPLE APPARATUS FOR DETECTING NEUROLOGICAL DEFICIT IN RATS AND MICE [J].
DUNHAM, NW ;
MIYA, TS .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (03) :208-209